Immunome, Inc. (IMNM)

Immunome Revenue

Immunome had revenue of $4.01M in the twelve months ending March 31, 2026, down -63.29% year-over-year. In the year 2025, Immunome had annual revenue of $6.94M, down -23.23%.

• Revenue (ttm): $4.01M
• Revenue Growth: -63.29%
• P/S Ratio: 563.01
• Revenue / Employee: $19,490
• Employees: 206
• Market Cap: 2.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.94M	-2.10M	-23.23%
Dec 31, 2024	9.04M	-4.98M	-35.50%
Dec 31, 2023	14.02M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error